Jianxiang Shi
- Cancer Research top 10%
- Cancer-related molecular mechanisms research 6
- Oncology top 10%
- Pancreatic and Hepatic Oncology Research 6
- Cancer Immunotherapy and Biomarkers 6
-
- Immunotherapy and Immune Responses 17
-
- Glycosylation and Glycoproteins Research 15
- Ubiquitin and proteasome pathways 6
-
- Monoclonal and Polyclonal Antibodies Research 29
-
- Ferroptosis and cancer prognosis 6
- Cited by
- Cancer ResearchOncologyImmunology
- Journals
- Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (1 paper)Cancer Research (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Jianxiang Shi
78 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 96
- Cancer Research 192
- Oncology 307
- Immunology 196
- Molecular Biology 546
- Radiology, Nuclear Medicine and Imaging 183
Countries citing papers authored by Jianxiang Shi
This map shows the geographic impact of Jianxiang Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jianxiang Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jianxiang Shi more than expected).
Fields of papers citing papers by Jianxiang Shi
This network shows the impact of papers produced by Jianxiang Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jianxiang Shi. The network helps show where Jianxiang Shi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jianxiang Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2025 | 3 | |
| 7 | 2024 | 1 | |
| 8 | 2024 | 0 | |
| 9 | 2024 | 1 | |
| 10 | 2023 | 2 | |
| 11 | 2023 | 1 | |
| 12 | 2023 | 37 | |
| 13 | 2023 | 9 | |
| 14 | 2023 | 4 | |
| 15 | 2023 | 9 | |
| 16 | 2023 | 8 | |
| 17 | 2022 | 24 | |
| 18 | 2021 | 18 | |
| 19 | 2021 | 8 | |
| 20 | 2011 | 21 |
About Jianxiang Shi
Jianxiang Shi is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Cancer Research, having authored 87 papers that have together received 1.0k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (29 papers), Immunotherapy and Immune Responses (17 papers), Glycosylation and Glycoproteins Research (15 papers), Ferroptosis and cancer prognosis (6 papers), Pancreatic and Hepatic Oncology Research (6 papers), Ubiquitin and proteasome pathways (6 papers), Cancer-related molecular mechanisms research (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). The work is most often cited by research in Cancer Research (192 citations), Oncology (307 citations) and Immunology (196 citations). Jianxiang Shi has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Liping Dai, Jianying Zhang, Peng Wang, Hua Ye, Jiejie Qin, Tiandong Li, Keyan Wang, Cuipeng Qiu, Guiying Sun and Kaijuan Wang. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.